Beck-Sickinger A G, Wieland H A, Wittneben H, Willim K D, Rudolf K, Jung G
Institut für Organische Chemie, Universität Tübingen, Germany.
Eur J Biochem. 1994 Nov 1;225(3):947-58. doi: 10.1111/j.1432-1033.1994.0947b.x.
The synthesis of more than fifty 36-residue oligopeptide analogs of neuropeptide Y (NPY) and their affinity to human Y1 and Y2 receptors is described. Each amino acid of the natural sequence was replaced by L-alanine, the four alanine residues at position 12, 14, 18 and 23 were replaced by glycine. Additional residues were exchanged to closely related ones in order to characterize the prerequisites for binding. A combination of automated single and multiple peptide synthesis using fluoren-9-ylmethoxycarbonyl/tert-butoxy strategy was applied. The purified peptides were characterized by electrospray mass spectrometry, analytical HPLC and amino acid analysis. Binding was investigated by displacement of 125I-labelled neuropeptide Y from human neuroblastoma cell lines SK-N-MC and SMS-KAN. Whereas Pro2 and the integrity of the neuropeptide Y loop is important for the binding to the Y1 receptor, exchanges within the C-terminal helix affect the affinity to the Y2 receptor. The C-terminal pentapeptide amide is important for both receptors and probably represents the binding site. However, Arg33 and Arg35 may not be exchanged by L-alanine in the Y1 system, whereas Arg35 and Tyr36 are the most susceptible residues in the Y2 system. In order to distinguish between conformational effects and direct hormone/receptor interaction via the side chains of neuropeptide Y, circular dichroic studies of the alanine-containing peptides were performed and structure affinity relationships are discussed. Comparing the affinities of the neuropeptide Y analogs to Y1 and Y2 receptors significant differences were found for the two binding sites, which suggests a different active conformation of neuropeptide Y at the two subtypes of receptors. Using molecular dynamics calculations, two distinct conformations were identified which are in good agreement with the data obtained by structure/affinity investigations.
本文描述了五十多种神经肽Y(NPY)的36个残基寡肽类似物的合成及其与人Y1和Y2受体的亲和力。天然序列中的每个氨基酸都被L-丙氨酸取代,第12、14、18和23位的四个丙氨酸残基被甘氨酸取代。为了确定结合的前提条件,还将其他残基替换为密切相关的残基。采用了芴甲氧羰基/叔丁氧基策略进行自动单肽和多肽合成。通过电喷雾质谱、分析型高效液相色谱和氨基酸分析对纯化的肽进行了表征。通过从人神经母细胞瘤细胞系SK-N-MC和SMS-KAN中置换125I标记的神经肽Y来研究结合情况。Pro2和神经肽Y环的完整性对于与Y1受体的结合很重要,而C末端螺旋内的置换会影响对Y2受体的亲和力。C末端五肽酰胺对两种受体都很重要,可能代表结合位点。然而,在Y1系统中,Arg33和Arg35不能被L-丙氨酸取代,而在Y2系统中,Arg35和Tyr36是最易被取代的残基。为了区分构象效应和神经肽Y侧链与激素/受体的直接相互作用,对含丙氨酸的肽进行了圆二色性研究,并讨论了结构亲和力关系。比较神经肽Y类似物对Y1和Y2受体的亲和力,发现两个结合位点存在显著差异,这表明神经肽Y在两种受体亚型上具有不同的活性构象。通过分子动力学计算,确定了两种不同的构象,这与结构/亲和力研究获得的数据高度一致。